Clinical outcomes and safety of tocilizumab in severe fever with thrombocytopenia syndrome: a retrospective multicenter cohort study. [PDF]
Front Cell Infect MicrobiolHu Q +8 more
europepmc +1 more source
Antibiotic and antiviral prescribing patterns among hospitalised patients with COVID-19 pneumonia in Mongolia: a real-world descriptive retrospective study. [PDF]
J Pharm Policy PractNyamdag N +3 more
europepmc +1 more source
Navigating Therapeutic Frontiers: A Meta-review and Meta-analysis of COVID-19 Treatment Options. [PDF]
J Res Pharm PractMousavi S, Ardekani MB, Feizi A.
europepmc +1 more source
Effect of the AHR Inhibitor CH223191 as an Adjunct Treatment for Mammarenavirus Infections. [PDF]
Int J Mol SciPelaez MA +4 more
europepmc +1 more source
Incidence, pathogenesis, clinical manifestations, and pharmacological management of the 2026 Andes virus outbreak. [PDF]
Virol JGhasemiyeh P, Mohammadi-Samani S.
europepmc +1 more source
Safety and efficacy of major antiviral and immune therapies in pregnancy for maternal viral infections: evidence synthesis of maternal and neonatal outcomes. [PDF]
Front Med (Lausanne)Sleman S +4 more
europepmc +1 more source
Novel green UPLC method with life cycle assessment for determination of favipiravir and molnupiravir drugs and environmental water samples. [PDF]
Sci RepKelani KM +4 more
europepmc +1 more source
A Case of Anabolic Steroid Demonstrating Efficacy in Improving Anorexia Associated with Severe Fever with Thrombocytopenia Syndrome. [PDF]
J Emerg Trauma ShockYanagawa Y +4 more
europepmc +1 more source
Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases. [PDF]
RSC AdvIsmail MMF +4 more
europepmc +1 more source
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice. [PDF]
Nat CommunAndreev K +5 more
europepmc +1 more source